Executive Search Success Story: Building a Leadership Team for a Diabetes & Insulin Delivery Device Manufacturer

How JRG Partners executed a confidential, multi-role North American and international retained search strategy that equipped a leading diabetes care and insulin delivery device manufacturer with the critical executive leadership required to scale growth, accelerate product innovation, and maintain regulatory compliance and patient safety in a highly competitive FDA-regulated environment.

The Challenge

A leading diabetes care and insulin delivery device manufacturer operating in a highly complex medical technology environment was entering a critical growth phase. To capitalize on market opportunities and protect its brands, the enterprise needed to scale its operations while strictly maintaining regulatory compliance and patient safety. Corporate leadership identified several critical structural and market pressures:

• Intensifying competition within the diabetes technology sector
• Increasing regulatory and quality requirements
• Demand for accelerated product innovation and commercialization
• Complex global supply chain and manufacturing operations
• Succession concerns across key leadership positions
• A need for executives able to scale growth while maintaining compliance and patient safety

The enterprise’s executive committee and board determined that stabilizing and scaling their global operations required a synchronized corporate management structure. The mandate included confidential recruitment across a Chief Operating Officer, VP Research & Development, VP Regulatory Affairs, VP Quality Assurance, VP Manufacturing, VP Commercial Operations, Director of Clinical Affairs, and diabetes product-development leaders. Successfully executing this multi-role mandate required an executive search firm combining deep technical vertical literacy in an FDA-regulated environment with a direct line to a national pool of passive talent. It needed a partner with deep diabetes-device search expertise.

Why They Chose JRG Partners

Deep Diabetes-Device Specialization

Unlike generalist recruiting agencies that lack functional immersion in highly sensitive and regulated environments, JRG Partners maintains dedicated search practices explicitly focused on diabetes technology, insulin delivery, regulatory affairs, quality systems, and commercial leadership. Our consultants carry a detailed operational understanding of the specialized governance standards required to support continuous growth.

Real Access to Passive Talent

Many of the strongest diabetes-device leaders are fully integrated into high-performing systems, meaning they rarely monitor traditional job listings. JRG Partners bypassed conventional recruitment channels entirely, leveraging long-standing relationships, proprietary market intelligence, and executive networks to reach high-performing passive leaders invisible through conventional sourcing methods.

Confidential Search Execution

With compliance and patient safety at stake, maintaining absolute discretion during this sensitive growth phase was mandatory. JRG Partners deployed a highly secure, confidential vetting and outreach framework that successfully insulated the client’s strategic positioning, protected continuity, and maintained total candidate trust throughout the transition lifecycle.

Broad Reach

Sourcing specialized medical device executives required an outreach strategy unconstrained by regional borders. The search targeted top-performing leaders from diabetes technology, insulin pump, and continuous glucose monitoring organizations across North America and select international corridors, providing corporate sponsors with an elite shortlist of proven lateral talent.

Our Corporate Search Strategy

Phase 1 — Leadership Assessment

Our consultants worked directly with the board and executive team to map organizational gaps, identify succession risks, clarify growth objectives, and define the exact leadership competencies the business would need as it scaled. Profiles were built dynamically against the company’s long-term strategy rather than legacy job descriptions.

Phase 2 — Market Mapping

JRG Partners executed an exhaustive market-mapping initiative across the medical technology ecosystem. Our comprehensive market map targeted key talent pools within diabetes technology companies, insulin pump manufacturers, continuous glucose monitoring organizations, medical device manufacturers, digital health companies, and biotechnology firms.

Phase 3 — Engagement

Using a research-driven, highly discreet outreach framework, our consultants directly contacted and evaluated high-achieving corporate leaders with verified records of scaling diabetes-device businesses under tight regulation. Only candidates demonstrating clear, measurable operational impact advanced to the final evaluation round.

Phase 4 — Assessment & Selection

Each finalist candidate underwent an extensive evaluation process looking far beyond basic credentials. Our consultants conversion-tested strategic and functional capabilities, regulatory agility, leadership and team-building philosophies, cultural alignment, and long-term retention potential.

Key Outcomes

• 450+ senior executives and product-development leaders systematically mapped and evaluated across major global medical device and diabetes technology hubs.
• Successfully placed and integrated a complete multi-role leadership framework—spanning the COO, VP R&D, VP Regulatory Affairs, VP Quality Assurance, VP Manufacturing, VP Commercial Operations, and Director of Clinical Affairs—within a 12-month timeline.
• Unified global cross-functional divisions under a synchronized corporate growth roadmap by installing process-driven transformation executives.
• Accelerated new product development and standardized regulatory pathways by placing forward-thinking R&D and regulatory leaders.
• Mitigated long-term organizational risks and optimized global manufacturing pipelines by placing specialized, data-driven operational leaders.
• Protected sensitive proprietary roadmaps, regulatory strategies, and expansion metrics during a high-stakes transition phase through strict search confidentiality.
• Provided the Board of Directors and CEO with a high-performance management framework explicitly equipped to eliminate compliance gaps and drive scalable commercial success under FDA regulation.